Endologix Inc. Reports First Quarter Results, Significant Increase In U.S. Product Sales

IRVINE, Calif.--(BUSINESS WIRE)--April 27, 2006--Endologix, Inc. (Nasdaq:ELGX - News), developer and manufacturer of the Powerlink® System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced financial results for the three months ended March 31, 2006.